Copy
When we think of drug development, we tend to imagine a scientist in a lab discovering a new compound with extraordinary new benefits. There are plenty of these stories in 25 Drugs, this month’s special issue of Texas Health Journal. Our researchers are discovering new drugs to combat pediatric cancer, addiction, lung disease, Duchenne muscular dystrophy, and more.

Drug development is more than this, however. It’s also developing the
delivery mechanisms so that drugs can get to where they need to be, while staying away from where they don’t. It’s discovering that old drugs, which are known to be effective for one disease, may also have immense benefits for another condition. It’s making basic science discoveries that bear pharmaceutical fruit forty years later. It’s combining two different drugs in novel ways. And it’s creating the institutions and platforms that enable researchers to collaborate, patent, test, and commercialize.

Across the System, our people and institutions are doing extraordinary work to develop and deliver the drugs that are saving and improving the lives of Texans. This is our most comprehensive issue of Texas Health Journal issue, but it’s only a small sample of that work.

Sincerely,

David Lakey, MD 
Vice Chancellor for Health Affairs and Chief Medical Officer 
The University of Texas System

@DavidLakey_MD 
CLICK TO SEE MORE
The Texas Health Journal is an ongoing digital effort to tell the story of how the 14 institutions that make up The University of Texas System are improving the health of Texans and people all over the world through education, research, and healthcare.

Have a story to share? Email Daniel Oppenheimer at
doppenheimer@utsystem.edu.
Subscribe to the Texas Health Journal or unsubscribe from this list.
 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
UT System Office of Health Affairs · 210 W. 7th St. · Austin, TX 78701 · USA